HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L'Oreal

This article was originally published in The Rose Sheet

Executive Summary

Department of Justice clears $250 mil. Carson acquisition, L'Oreal announces Aug. 1. A tender cash offer for all outstanding Carson Class A common stock will be extended at $5.20 per share. DoJ orders L'Oreal to divest Carson's Gentle Treatment, Johnson Products and Ultra Sheen Supreme, but allows the firm to retain its main interests, the Dark & Lovely, Magic Shave and Dermablend businesses. The antitrust review, which began in April, was initiated because the deal would have given L'Oreal a 33% share in the ethnic hair care market (1"The Rose Sheet" April 3, In Brief)

You may also be interested in...



Johnson Gentle Treatment Re-launch Is First Initiative Under Wella

Johnson Products' revamp of its Gentle Treatment No-Lye Conditioning Creme Relaxer involves updated packaging, improved formulation benefits and a new ad campaign, the Wella division said.

Johnson Gentle Treatment Re-launch Is First Initiative Under Wella

Johnson Products' revamp of its Gentle Treatment No-Lye Conditioning Creme Relaxer involves updated packaging, improved formulation benefits and a new ad campaign, the Wella division said.

L'Oreal's Soft Sheen, Carson Merge Into Ethnic Beauty Division

L'Oreal USA's Soft Sheen ethnic hair care division will merge with newly acquired Carson to form an "ethnic beauty headquarters" based in Chicago, L'Oreal (formerly Cosmair) announced Aug. 23. The move follows the U.S. government's approval of the merger between the companies.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008289

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel